Ledger.Open graph →
SEC Form D · filed September 23, 2022

ABK Biomedical Inc

Offering
$18.1M
Sold
$18.1M
Exemption
Rule 506(b)
Industry
Other
Location
HALIFAX, Nova Scotia, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (30)

Anthony Headley · Halifax, Nova Scotia, CanadaExecMike Tyson · Halifax, Nova Scotia, CanadaExecMarc Gregoire · Halifax, Nova Scotia, CanadaExecAaron Berez · Halifax, Nova Scotia, CanadaDirectorKetan Patel · Halifax, Nova Scotia, CanadaDirectorAravind Arepally · Halifax, Nova Scotia, CanadaExecJames B. Mclaren · Halifax, Nova Scotia, CanadaDirectorDavid Dobrowsky · Halifax, Nova Scotia, CanadaExecGary Donofrio · Halifax, Nova Scotia, CanadaExecMichael Mangano · Halifax, Nova Scotia, CanadaExec · DirectorDavid T. Dart · Lewisville, TXExecMichael Peck · Chicago, ILDirectorAndrew Kaufmann · Jacksonville, FLExecJustin Elliott · Minneapolis, MNDirectorHami T. Ebrahimi · Lewisville, TXExec · DirectorChad Eisenberg · Chicago, ILExecChristopher Hathorn · Dallas, TXExecDan Bonne · Minneapolis, MNDirectorSteven T. Grimshaw · Lewisville, TXExecJonathan T. Seiffer · Lewisville, TXExecAnton V. Zavyalov · London, United KingdomExecPavel Mamai · London, United KingdomExecBrooks Norris · For Smith, ARExecScot Melland · Toronto, Ontario, CanadaExec · DirectorBrandon Mcneil · Toronto, Ontario, CanadaExecThomas Cahill · Miami, FLDirectorJonathan Bull · Co. Dublin, IrelandDirectorAndrew Barr · Berkeley, CAExecCcf GP, LLC · Greenwich, CTExecWesley N. Tang-Wymer · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗